10 years or more, many domestic pharmaceutical companies in Korea have devoted significant efforts to the development of blockbuster-type biopharmaceuticals. Recently, major domestic corporations, mid-sized pharmaceutical companies, and ventures have achieved remarkable results, such as launching new drugs for massive technology exports and overseas expansion. The medical protein and enzyme biopharmaceutical sectors have large domestic and international market sizes and high technological complexity, making market entry for domestic ventures and small businesses extremely challenging. To overcome these barriers and establish a system for concentrated support of essential scientific technologies and rapid enhancement of domestic and international competitiveness, the "DGIST Core Protein Resources Center" has been established. Below are the three visions of this center:
The goal of this center is to consolidate four essential core resources (skilled workforce, research and development facilities, protein information resources, protein analysis and related technologies) necessary for the development and production of useful proteins and enzymes directly or indirectly utilized in the medical and medical-related industries. By concentrating these resources, the center aims to efficiently support leading domestic bio-companies with the best available commercialization technologies.
Through proactive acquisition of commercializable protein and enzyme resources and related technologies, the center aims to establish a technology support center that minimizes the financial and time burdens of research and development for companies. This will be achieved through a division of labor between companies and the center, aligning with the slogan "Resources Service Center, Only One Step Away from Business," enabling innovative forms of support for businesses in their research and development endeavors.
The establishment of a cutting-edge public research institute focused on the development of high-value medical proteins requires concentration of four core resources: useful protein resources, research and development production facilities, key technological elements, and specialized workforce. This aims to provide a public foundation to support the overseas expansion and new startups in the domestic protein biopharmaceutical industry. To achieve this, the following seven specific bases will be established:
Choi, Seong Kyoon
+82-53-785-2562
cskbest@dgist.ac.kr